Available EXPANDED_ACCESS NCT02065674

Therapeutic Efficacy of Abroma Agusta in HbA1c % in NIDDM (ABOMNIDDM)

Therapeutic Efficacy of Homoeopathic Mother Tincture of Abroma Agusta in Changing the Level of Glycated Hb (HbA1c %) in Diabetes Mellitus Type II (NIDDM

Sponsor: Fr Muller Homoeopathic Medical College

Conditions Type II Diabetes Mellitus

Interventions Abroma Augusta Q (mother tincture)

Updated 8 times since 2017 Last updated: Jun 5, 2015 Started: Feb 28, 2014 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Type II Diabetes Mellitus and is currently ongoing. Fr Muller Homoeopathic Medical College leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Available
Jul 2024 — Sep 2024 [monthly]

Available
Jan 2021 — Jul 2024 [monthly]

Available
Jun 2018 — Jan 2021 [monthly]

Available
Apr 2018 — Jun 2018 [monthly]

Available

Phase: NA → None

▶ Show 3 earlier versions

Jul 2017 — Apr 2018 [monthly]

Available NA

Phase: PHASE2 → NA
Feb 2017 — Jul 2017 [monthly]

Available PHASE2
Jan 2017 — Feb 2017 [monthly]

Available PHASE2

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fr Muller Homoeopathic Medical College

Data source: Fr Muller Homoeopathic Medical College

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mangalore, India